Overview: IgA Subclasses TestIntroduction: The IgA Subclasses Test measures IgA subclasses (IgA1 and IgA2) to diagnose immune deficiencies, causing recurrent infections. Aligned with 2023 AAAAI guidelines, it uses immunoassays for high accuracy, supporting immune screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in immunology for patients with suspected immune deficiencies.
Other Names: IgA Subclass Assay, Immunoglobulin A Subclasses Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: IgA subclass testing began in the 1980s with immune deficiency research. Immunoassay-based methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures IgA subclasses to diagnose immune deficiencies, guides treatment, and evaluates patients with recurrent infections.
Test Parameters: 1. IgA Subclasses
Pretest Condition: No fasting required. Collect serum at any time. Report history of recurrent infections or immune deficiencies.
Specimen: 2-5 mL serum (SST). Centrifuge within 1 hour. Transport in a biohazard bag.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document recurrent infections, sinusitis, or family history of immune deficiencies. Include current medications, especially immunoglobulins.
Consent: Written consent required, detailing the tests purpose, immune deficiency implications, and potential need for immunoglobulin therapy.
Procedural Considerations: Uses immunoassays to measure IgA1 and IgA2 levels. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for immune deficiency assessment.
Factors Affecting Result Accuracy: Improper sample handling or contamination can affect results. Recent infections may influence IgA levels.
Clinical Significance: Low IgA subclasses suggest immune deficiency, guiding immunoglobulin therapy or infection management. Normal levels may require further immune testing.
Specialist Consultation: Consult an immunologist for result interpretation and treatment planning.
Additional Supporting Tests: IgG, IgM levels, or lymphocyte subset analysis to assess immune function.
Test Limitations: Not specific to IgA deficiency; other immune defects may cause similar symptoms. Clinical correlation is needed.
References: AAAAI Immune Deficiency Guidelines, 2023; Journal of Allergy and Clinical Immunology, Bonilla FA, 2022.
